[Ip-health] Opinion Piece - India's new pharma FDI policy undermines competition and paves the way for for multinational pharma corporations to take over Indian generic companies

leena menghaney leenamenghaney at gmail.com
Fri Jul 1 06:09:08 PDT 2016


The Union government’s decision to allow up to 74% foreign direct
investment in pharmaceutical companies through the automatic route could
threaten competition in the pharmaceutical sector and India’s role as a
supplier of low cost, life-saving drugs across the developing world.

http://scroll.in/article/810499/the-new-pharma-fdi-policy-undermines-indian-generics-which-may-make-drugs-more-expensive

Published in Scroll.in

-- 
Leena Menghaney
Mobile: 9811365412



More information about the Ip-health mailing list